Following a regulatory win in the U.S., recently re-branded Alere, formerly MedApps, said it will roll out its 1st cloud-based remote patient monitoring device later this year.
The device, called MobileLink, is an at-home self-diagnosis system that links to the company’s Connected Health platform, plugging patients in to various wellness networks and to a personal electronic health record.
The Waltham, Mass.-based company said it will ultimately offer diagnosis for a variety of diseases, but the 1st wave of MobileLink devices, called the INRatio2 PT/INR Monitor, are specifically for patients on anticoagulant medications such as warfarin.
The company will soon introduce a monitoring system for patients managing multiple disease at once, and later a more sophisticated touch-screen interface device, according to MobiHealthNews.
The 510(k) follows European CE Mark for MobileLink. In the States, MobileLink is cleared for use with other at-home monitoring devices, like weight scales, blood pressure cuffs and glucose meters.
"Our devices are being used to supply patient data directly into the provider’s electronic health records system – integration is key," said CEO Kent Dicks in prepared remarks. "The platform captures and analyses data with robust analytics, and then backs it up with comprehensive health management services."